The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.

Autor: Tward J; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: jonathan.tward@hci.utah.edu., Lenz L; Myriad Genetics, Inc, Salt Lake City, Utah., Flake DD II,; Myriad Genetics, Inc, Salt Lake City, Utah., Rajamani S; Myriad Genetics, Inc, Salt Lake City, Utah., Yonover P; UroPartners, Chicago, Illinois., Olsson C; Advanced Radiation Center of New York, New Hyde Park, New York, and Integrated Medical Professionals, North Hills, New York., Kapoor DA; Advanced Radiation Center of New York, New Hyde Park, New York, and Integrated Medical Professionals, North Hills, New York., Mantz C; 21st Century Oncology, Fort Meyers, Florida., Liauw SL; Department of Radiation Oncology, University of Chicago Medical Center, Chicago, Illinois., Antic T; Department of Pathology, University of Chicago Medical Center, Chicago, Illinois., Fabrizio M; Urology of San Antonio, San Antonio, TX., Salzstein D; Urology of Virginia, Norfolk, Virginia., Shore N; Carolina Urologic Research Center, Myrtle Beach, South Carolina., Albertson D; Department of Anatomic Pathology and Molecular Oncology, University of Utah, Salt Lake City, Utah., Henderson J; Regional Urology, LLC, Shreveport, Louisiana., Lee SP; Department of Radiation Oncology, Long Beach VA Medical Center, Long Beach, California., Gay HA; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Michalski J; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Hung A; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon., Raben D; University of Colorado, Aurora, Colorado., Garraway I; Department of Urology, Greater Los Angeles-VA Medical Center, Los Angeles, California., Lewis MS; Department of Urology, Greater Los Angeles-VA Medical Center, Los Angeles, California., Nguyen PL; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Marshall DT; Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina., Brawer MK; Myriad Genetics, Inc, Salt Lake City, Utah., Stone S; Myriad Genetics, Inc, Salt Lake City, Utah., Cohen T; Myriad Genetics, Inc, Salt Lake City, Utah.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 May 01; Vol. 113 (1), pp. 66-76. Date of Electronic Publication: 2021 Oct 03.

Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis.

Autor: Baker, Joshua F., ODell, James R., England, Bryant R., Giles, Jon T., Newcomb, Jefferey A., George, Michael D., Thiele, Geoffrey, Moreland, Larry, Bridges, S. Louis, Curtis, Jeffrey R., Mikuls, Ted R.

Publikováno v: Annals of the Rheumatic Diseases; Apr2024, Vol. 83 Issue 4, following p429-436, 22p

PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.

Autor: Gradecki, Sarah E¹ (AUTHOR) seg5f@hscmail.mcc.virginia.edu, Valdes‐Rodriguez, Rodrigo² (AUTHOR), Wick, Mark R¹ (AUTHOR), Gru, Alejandro A¹ (AUTHOR)

Publikováno v: Histopathology. Jun2021, Vol. 78 Issue 7, p1000-1008. 9p.

Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing.

Autor: Lenz L; Myriad Genetics, Inc., Salt Lake City, UT, USA., Clegg W; Myriad Genetics, Inc., Salt Lake City, UT, USA., Iliev D; Myriad Genetics, Inc., Salt Lake City, UT, USA., Kasten CR; Myriad Genetics, Inc., Salt Lake City, UT, USA., Korman H; Comprehensive Urology, Royal Oak, MI, USA.; Wayne State University, Detroit, MI, USA., Morgan TM; University of Michigan, Ann Arbor, MI, USA., Hafron J; Michigan Institute of Urology, Troy, MI, USA., DeHaan A; Urologic Consultants, Wyoming, MI, USA., Olsson C; Integrated Medical Professionals, Melville, NY, USA., Tutrone RF Jr; Chesapeake Urology, Towson, MD, USA., Richardson T; Wichita Urology, Pratt, KS, USA., Cline K; Regional Urology, Shreveport, LA, USA., Yonover PM; UroPartners, Chicago, IL, USA., Jasper J; Myriad Genetics, Inc., Salt Lake City, UT, USA., Cohen T; Myriad Genetics, Inc., Salt Lake City, UT, USA., Finch R; Myriad Genetics, Inc., Salt Lake City, UT, USA., Slavin TP Jr; Myriad Genetics, Inc., Salt Lake City, UT, USA., Gutin A; Myriad Genetics, Inc., Salt Lake City, UT, USA. agutin@myriad.com.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.

A diagnostically‐challenging case of melanoma ex blue nevus with comprehensive molecular analysis, including the 23‐gene expression signature (myPath melanoma).

Autor: Castillo, Stephanie A.¹, Pham, Anh K.², Barton, Dorothea T.^1,2, Lefferts, Joel A.^1,3, Yan, Shaofeng^1,3, Bridge, Julia A.⁴, Linos, Konstantinos^1,3 konstantinos.linos@hitchcock.org

Publikováno v: Journal of Cutaneous Pathology. Mar2019, Vol. 46 Issue 3, p226-230. 5p. 2 Color Photographs, 1 Graph.